Antimicrobial Resistance: An Emerging Global Threat to Modern Medicine

  26 November 2025

The article highlights how the rapid rise of drug-resistant bacteria, viruses, fungi, and parasites is undermining the foundations of modern healthcare, threatening to make routine infections harder—and sometimes impossible—to treat. AMR is driven primarily by the misuse and overuse of antimicrobials in human medicine, livestock production, and the environment, combined with weak infection-prevention systems and limited surveillance capacity in many countries. As resistance accelerates, essential medical procedures such as surgeries, organ transplants, dialysis, and cancer chemotherapy become far riskier due to the heightened chance of untreatable infections. The article emphasises the growing global burden of AMR, including increasing mortality, prolonged hospital stays, and escalating healthcare costs, while also stressing the urgent need for coordinated global action: strengthening stewardship, improving sanitation and vaccination, advancing diagnostics, incentivising new antimicrobials, and reducing inappropriate antibiotic exposure across all sectors.

Further reading: Cureus
Author(s): Esteban Zavaleta-Monestel et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!